SALT LAKE CITY, Oct. 5 /PRNewswire/ — Axial Biotech, Inc., a
company revolutionizing spine care through the development of
molecular diagnostic technologies, was selected as a winner at the
2010 Spine Technology Awards. Sponsored by Orthopedics This
Week, the largest weekly publication in the spine industry, the
2010 Spine Technology Awards received submissions from hundreds of
outstanding technologies. Robin Young, the Publisher of
Orthopedics This Week, presented the award to Axial Biotech
during an awards ceremony held last night, in advance of the North
American Spine Society Meeting in Orlando, Florida

Axial Biotech’s award winning product, ScoliScore™AIS
Prognostic Test, won in the diagnostics category. The ScoliScore
test is the first-ever genetic test for patients diagnosed with
Adolescent Idiopathic Scoliosis (AIS). This new molecular
diagnostic tool marks a major advancement in which medical
treatments can be personalized to patients diagnosed with this
deforming disease.

ScoliScore™ was developed by utilizing a genome wide
association study that identified a panel of genetic markers
associated with severe curve progression. The scoliosis research
used in the development of this test included collecting DNA
samples from over 10,000 patients from over 100 IRB approved
clinical sites throughout the world. The test was then further
validated in three separate clinical trials.

The Spine Technology Awards were judged according to their
likelihood to advance the care of spine care and treatment using
innovative and new technologies. The 30-surgeon panel of judges was
selected for their clinical experience and independence — none
were affiliated with the winning technologies. Since treating
spinal disorders is one of the most complex medical problems, new
technologies have historically played a significant role in
advancing the cause of patient care.

Speaking at the awards gala, Orthopedics This Week

‘/>”/>

SOURCE